S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
The single greatest medical breakthrough of all time? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
The single greatest medical breakthrough of all time? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
The single greatest medical breakthrough of all time? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
The single greatest medical breakthrough of all time? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
The single greatest medical breakthrough of all time? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
NASDAQ:FONR

FONAR (FONR) Stock Forecast, Price & News

$15.40
-0.45 (-2.84%)
(As of 09/29/2023 ET)
Compare
Today's Range
$15.12
▼
$15.93
50-Day Range
$15.40
▼
$17.16
52-Week Range
$13.73
▼
$19.00
Volume
22,828 shs
Average Volume
9,406 shs
Market Capitalization
$100.72 million
P/E Ratio
11.67
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

FONR stock logo

About FONAR (NASDAQ:FONR) Stock

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 41 MRI scanning facilities, including 26 facilities located in New York and 15 facilities located in Florida. The company markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

FONR Price History

FONR Stock News Headlines

September 28, 2023 | finanznachrichten.de
Fonar Corporation: FONAR Announces Financial Results for Fiscal 2023
September 27, 2023 | americanbankingnews.com
FONAR (NASDAQ:FONR) Share Price Passes Below 200 Day Moving Average of $16.53
September 30, 2023 | Chaikin Analytics (Ad)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
September 4, 2023 | finance.yahoo.com
Pleasing Signs As A Number Of Insiders Buy FONAR Stock
August 3, 2023 | msn.com
Back Into FONAR Corporation
July 15, 2023 | finance.yahoo.com
Some Investors May Be Worried About FONAR's (NASDAQ:FONR) Returns On Capital
June 26, 2023 | thestreet.com
Fonar Shares Drop on Volume Spike
June 7, 2023 | finance.yahoo.com
FONAR Corporation's (NASDAQ:FONR) top owners are retail investors with 49% stake, while 46% is held by institutions
September 30, 2023 | Chaikin Analytics (Ad)
Wall Street Legend Warns "Mass Bank Run" is Coming
Man who predicted 2023 bank run warns it could soon get worse. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more.
May 15, 2023 | finanznachrichten.de
Fonar Corporation: Fonar Announces Financial Results for Fiscal 2023 3rd Quarter and Nine-Month Period
May 15, 2023 | finance.yahoo.com
Fonar Announces Financial Results for Fiscal 2023 3rd Quarter and Nine-Month Period
April 23, 2023 | finance.yahoo.com
Investors in FONAR (NASDAQ:FONR) have unfortunately lost 43% over the last five years
March 28, 2023 | finance.yahoo.com
Great news for FONAR Corporation (NASDAQ:FONR): Insiders acquired stock in large numbers last year
February 5, 2023 | finance.yahoo.com
FONAR (NASDAQ:FONR) Could Be Struggling To Allocate Capital
December 29, 2022 | finance.yahoo.com
While institutions own 39% of FONAR Corporation (NASDAQ:FONR), individual investors are its largest shareholders with 50% ownership
November 30, 2022 | finance.yahoo.com
Fonar Corporation Designates Laurel Hill Advisory Group, LLC as Information Agent for the Company's $9 Million Share Repurchase Program
November 17, 2022 | finance.yahoo.com
FONAR Reports First Quarter 2023 Earnings
November 14, 2022 | finance.yahoo.com
Investors in FONAR (NASDAQ:FONR) have unfortunately lost 23% over the last five years
October 25, 2022 | nasdaq.com
Fonar Corporation Common Stock (FONR)
October 24, 2022 | reuters.com
FONR.A - Fonar Corporation | Stock Price & Latest News | Reuters
October 19, 2022 | finance.yahoo.com
Quite a few insiders invested in FONAR Corporation (NASDAQ:FONR) last year which is positive news for shareholders
October 17, 2022 | streetinsider.com
Statera Biopharma Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam's Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients - StreetInsider.com
October 17, 2022 | streetinsider.com
Statera Biopharma (STAB) Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam's Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients - StreetInsider.com
October 13, 2022 | globenewswire.com
Global MR Imaging in Neurosurgery Market Analysis Report 2021-2031: Opportunities in the Development of Cost-Effective Robotic-Assisted MRI Systems and MRI-Compatible Robotic Systems - GlobeNewswire
October 7, 2022 | benzinga.com
MRI System Market Expected to Increase 1.7x During 2022-2030 | Soaring Prevalence of Chronic Diseases Pri - Benzinga
October 6, 2022 | nasdaq.com
A Look At The Intrinsic Value Of FONAR Corporation (NASDAQ:FONR) - Nasdaq
October 6, 2022 | nasdaq.com
A Look At The Intrinsic Value Of FONAR Corporation (NASDAQ:FONR)
See More Headlines
Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

FONR Company Calendar

Last Earnings
5/11/2020
Today
9/30/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FONR
CUSIP
N/A
CIK
355019
Web
www.fonar.com
Phone
(631) 694-2929
Fax
631-753-5150
Employees
484
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$1.32
Trailing P/E Ratio
11.67
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$12.44 million
Net Margins
9.49%
Pretax Margin
17.11%
Return on Equity
6.31%
Return on Assets
4.73%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
8.76
Quick Ratio
8.57

Sales & Book Value

Annual Sales
$98.64 million
Price / Sales
1.02
Cash Flow
$3.82 per share
Price / Cash Flow
4.03
Book Value
$22.31 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
6,540,000
Free Float
5,977,000
Market Cap
$100.72 million
Optionable
Not Optionable
Beta
0.90
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Timothy R. Damadian M.D. (Age 59)
    Chairman, Pres, CEO & Treasurer
    Comp: $305.8k
  • Mr. Luciano B. Bonanni (Age 68)
    COO, Exec. VP & Acting Principal Financial Officer
    Comp: $454.37k
  • Ms. Claudette J. V. Chan (Age 85)
    Sec. & Director
    Comp: $58.88k
  • Mr. Daniel Culver
    Director of Communications

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













FONR Stock - Frequently Asked Questions

How have FONR shares performed in 2023?

FONAR's stock was trading at $16.75 at the start of the year. Since then, FONR stock has decreased by 8.1% and is now trading at $15.40.
View the best growth stocks for 2023 here.

Are investors shorting FONAR?

FONAR saw a increase in short interest in September. As of September 15th, there was short interest totaling 16,700 shares, an increase of 16.8% from the August 31st total of 14,300 shares. Based on an average daily trading volume, of 7,900 shares, the short-interest ratio is presently 2.1 days. Currently, 0.3% of the company's stock are sold short.
View FONAR's Short Interest.

When is FONAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our FONR earnings forecast.

How were FONAR's earnings last quarter?

FONAR Co. (NASDAQ:FONR) released its quarterly earnings data on Monday, May, 11th. The medical equipment provider reported $0.18 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $21.69 million for the quarter. FONAR had a trailing twelve-month return on equity of 6.31% and a net margin of 9.49%.

What other stocks do shareholders of FONAR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC), Incyte (INCY), Jazz Pharmaceuticals (JAZZ), Lannett (LCI) and Madrigal Pharmaceuticals (MDGL).

What is FONAR's stock symbol?

FONAR trades on the NASDAQ under the ticker symbol "FONR."

How do I buy shares of FONAR?

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is FONAR's stock price today?

One share of FONR stock can currently be purchased for approximately $15.40.

How much money does FONAR make?

FONAR (NASDAQ:FONR) has a market capitalization of $100.72 million and generates $98.64 million in revenue each year. The medical equipment provider earns $12.44 million in net income (profit) each year or $1.32 on an earnings per share basis.

How many employees does FONAR have?

The company employs 484 workers across the globe.

How can I contact FONAR?

FONAR's mailing address is 110 Marcus Drive, Melville NY, 11747. The official website for the company is www.fonar.com. The medical equipment provider can be reached via phone at (631) 694-2929, via email at investor@fonar.com, or via fax at 631-753-5150.

This page (NASDAQ:FONR) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -